The Growing Role of Prostacyclin Analog Therapy in Pulmonary Arterial Hypertension Drugs
The management of pulmonary arterial hypertension (PAH) has been transformed by the development of prostacyclin analog therapies, with iloprost emerging as a key treatment option. Iloprost, a synthetic prostacyclin analog, works by dilating blood vessels and inhibiting platelet aggregation, improving hemodynamics and exercise capacity in patients with PAH. The Iloprost Market is...
0 Reacties 0 aandelen 39 Views 0 voorbeeld